Abbott Laboratories 

ABT:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
42.73 0.00   0.00%2.06%9907.0M
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

As of 03:59 PM ET 7/18/2014

Latest News Headlines for Abbott Laboratories

Health Care Equipment Equities Technical Notes -- Medtronic, Abbott Laboratories, Stryker, Zimmer Holdings, and EnteroMedics

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 21, 2014 /PRNewswire/ -- On Friday, July 18, 2014, the NASDAQ Composite ended at 4,432.15, up 1.57%, the Dow Jones Industrial Average advanced 0.73%, to finish the day at 17,100.18, and the S&P; 500 closed at 1,978.22, up 1.03%. The gains were broad based with all the ten sectors ending the session in positive. The S&P; 500 Health Care Sector Index ended the day at 710.68, up 1.63%, with the index advancing 6.63% in the previous three months. Investor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Stryker Corporation (NYSE: SYK), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). Free research on these five companies can be accessed at:

Abbott Reports Second-Quarter 2014 Results -5-

Operations before taxes 1,160 655 1,815 Taxes on Earnings from Continuing Operations 361 (16) 345 Net Earnings from Continuing

Abbott Reports Second-Quarter 2014 Results -4-

Diluted Earnings per Common Share from Continuing Operations, excluding Specified Items, as described below $0.54 $0.46 17.4 3) ====== ======

View more recent headlines

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. In August 2013, Abbott Laboratories completed its acquisition of OptiMedica Corporation. In August 2013, Abbott Laboratories completed its acquisition of IDEV Technologies.

http://www.abbott.com

Loading...
Bid/SizeAsk/Size
-- / ---- / --
Price OpenPrevious Close
0.0042.73
Day HighDay Low
----
52wk High/Date52wk Low/Date
42.99 / 7/17/201432.70 / 9/3/2013
% off 52wk High% off 52wk Low
-0.60%30.67%
Beta (5 Yr)Market Capitalization
0.664.2B Large Cap
Shares OutstandingVolatility Avg
1.5B16.69
EPS(TTM)P/E Ratio
1.3930.7
Dividend AnnouncementDividend Yield
6/13/20142.06%
Ex-DateDate of Record
7/11/20147/15/2014
PayablePayable Date
0.22 - QRTR8/15/2014

Last Trade as of 7/18/2014 4:02 PM ET

Peers Information HelpABT Abbott Laboratories vs. Peers

Peers 
ABT
Abbott Laboratories
11.48%
Johnson & Johnson
11.15%
Pfizer Inc.
0.33%
Merck & Co., Inc.
16.56%
Eli Lilly and Co
24.45%
ABT
Abbott Laboratories
2.06%
Johnson & Johnson
2.75%
Pfizer Inc.
3.38%
Merck & Co., Inc.
3.02%
Eli Lilly and Co
3.09%
ABT
Abbott Laboratories
0.00%
Johnson & Johnson
0.00%
Pfizer Inc.
0.00%
Merck & Co., Inc.
0.00%
Eli Lilly and Co
0.00%
Compare these stocks